Results 111 to 120 of about 5,633 (190)

Uric Acid and Chronic Kidney Disease. [PDF]

Kidney Med
Yadlapalli S, Nekkalapudi DK, Wish JB.
europepmc   +1 more source

Design, Synthesis, and Anticancer Evaluation of Febuxostat-Based Triazolyl Derivatives. [PDF]

Arch Pharm (Weinheim)
Lu Y, Wang H, Yan D, He B, Guo J, Hou X, Liu L.   +6 more
europepmc   +1 more source

Febuxostat administration for the prevention of tumour lysis syndrome: A meta-analysis

, 2019
What is known and objective: Tumour lysis syndrome is an oncological emergency, characterized by rapid cytolysis leading to an abrupt rise of serum uric acid levels.
Bellos, I., Kontzoglou, K., Pergialiotis, V., Psyrri, A.   +3 more
core  

Treatment sequence patterns of urate-lowering therapy in Korean patients with gout: A common data model-based study. [PDF]

PLoS One
Kim MJ, Park EG, Kim C, Kang DY, Ryu B, Shin K.   +5 more
europepmc   +1 more source

Effect of dotinurad versus febuxostat on the one-year eGFR slope in CKD patients with hyperuricemia: a retrospective cohort study. [PDF]

BMC Nephrol
Uematsu H, Toida T, Tanaka Y, Joki N.
europepmc   +1 more source

Febuxostat effectively reduces uric acid but has a limited renoprotective effect on renal transplant recipients with hyperuricemia: a meta-analysis. [PDF]

Front Pharmacol
Chao S, Zhu K, Jia L, Liu Y.
europepmc   +1 more source

Successful Extended Allopurinol Desensitization in an Elderly Patient With Chronic Kidney Disease and Febuxostat Intolerance. [PDF]

Cureus
Ramesh R, Nagaraja V, Gonzalez-Estrada A.   +2 more
europepmc   +1 more source

Efectividad del febuxostat en pacientes hiperuricémicos. Revisión sistemática

La hiperuricemia es una patología crónica curable causada por el depósito de cristales de urato monosódico en articulaciones y tejidos periarticulares, como consecuencia del incremento de ácido úrico sérico.
Calle Crespo, Víctor Manuel
core  

Allopurinol and Febuxostat Hypersensitivity in a Patient with Young Onset Gout: A Case Report. [PDF]

Acta Med Philipp
Yano MAO, Magbitang-Santiago AT.
europepmc   +1 more source

Machine learning-based prediction model for drug target identification and MASH improvement: a comprehensive analysis of biochemical and ferroptosis/autophagy biomarkers. [PDF]

J Physiol Biochem
Matboli M, Elanwar A, Khaled R, Khaled A, Eltantawy EHB, Hamam GG, Ahmed MY, Fouad M, Tarek AA, Elmasry M, El-Shafei MM, Aboulhoda BE, Diab GI, Aboughaleb IH.   +13 more
europepmc   +1 more source